TY - JOUR
T1 - Bifidobacterium bacteraemia is rare with routine probiotics use in preterm infants: A further case report with literature review
AU - Acuna-Gonzalez, Antia
AU - Kujawska, Magdalena
AU - Youssif, Mayada
AU - Atkinson, Thomas
AU - Grundy, Sara
AU - Hutchison, Alexandra
AU - Tremlett, Catherine
AU - Clarke, Paul
AU - Hall, Lindsay J.
N1 - Funding Information: L.J.H. is supported by Wellcome Trust Investigator Awards 100974/C/13/Z and 220876/Z/20/Z ; the Biotechnology and Biological Sciences Research Council (BBSRC), Institute Strategic Programme Gut Microbes and Health BB/R012490/1, and its constituent projects BBS/E/F/000PR10353 and BBS/E/F/000PR10356.
PY - 2023/4
Y1 - 2023/4
N2 - Prophylactic administration of oral probiotics is associated with significant reductions in the morbidity and mortality of necrotising enterocolitis in preterm infants. We document the first case of Bifidobacterium longum subsp. infantis sub-clinical bacteraemia, in an extremely low birth weight preterm infant, since introduction of routine probiotic treatment at the Norfolk and Norwich University Hospital 10 years ago. Whole genome comparisons confirmed the isolated strain likely originated from the probiotic product.
AB - Prophylactic administration of oral probiotics is associated with significant reductions in the morbidity and mortality of necrotising enterocolitis in preterm infants. We document the first case of Bifidobacterium longum subsp. infantis sub-clinical bacteraemia, in an extremely low birth weight preterm infant, since introduction of routine probiotic treatment at the Norfolk and Norwich University Hospital 10 years ago. Whole genome comparisons confirmed the isolated strain likely originated from the probiotic product.
UR - http://www.scopus.com/inward/record.url?scp=85147860379&partnerID=8YFLogxK
U2 - 10.1016/j.anaerobe.2023.102713
DO - 10.1016/j.anaerobe.2023.102713
M3 - Article
VL - 80
JO - Anaerobe
JF - Anaerobe
SN - 1075-9964
M1 - 102713
ER -